Procter & Gamble Health Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Dec 2025 is 20.69% vs -0.06% in Dec 2024

Standalone Net Profit

YoY Growth in quarter ended Dec 2025 is -14.64% vs 26.13% in Dec 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is -10.51% vs 21.43% in Dec 2024

Interest

YoY Growth in quarter ended Dec 2025 is -33.33% vs -21.05% in Dec 2024

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024

Compare Quarterly Results Of P & G Health Ltd With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

373.86

165.70

208.16

125.62%

Other Operating Income

0.00

Total Operating income

373.86

165.70

208.16

125.62%

Raw Material Cost

84.47

54.03

30.44

56.34%

Purchase of Finished goods

13.32

6.32

7.00

110.76%

(Increase) / Decrease In Stocks

12.03

11.55

0.48

4.16%

Employee Cost

61.81

30.75

31.06

101.01%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

91.77

32.05

59.72

186.33%

Total Expenditure (Excl Depreciation)

263.40

134.70

128.70

95.55%

Operating Profit (PBDIT) excl Other Income

110.46

31.00

79.46

256.32%

Other Income

4.36

11.29

-6.93

-61.38%

Operating Profit (PBDIT)

114.82

42.29

72.53

171.51%

Interest

0.10

2.74

-2.64

-96.35%

Exceptional Items

0.00

-2.20

2.20

100.00%

Gross Profit (PBDT)

114.72

37.35

77.37

207.15%

Depreciation

5.90

13.56

-7.66

-56.49%

Profit Before Tax

108.82

23.79

85.03

357.42%

Tax

31.23

7.85

23.38

297.83%

Provisions and contingencies

0.00

Profit After Tax

77.59

15.93

61.66

387.07%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

77.59

15.93

61.66

387.07%

Equity Capital

16.60

19.56

-2.96

-15.13%

Face Value

10.00

1.00

0.00

Reserves

0.00

Earnings per share (EPS)

46.74

0.81

45.93

5,670.37%

Diluted Earnings per share

46.74

0.84

45.90

5,464.29%

Operating Profit Margin (Excl OI)

29.55%

18.71%

0.00

10.84%

Gross Profit Margin

30.69%

22.54%

0.00

8.15%

PAT Margin

20.75%

9.61%

0.00

11.14%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 373.86 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 15.06% vs -4.08% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 20.69% vs -0.06% in Dec 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 77.59 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -12.37% vs 33.79% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -14.64% vs 26.13% in Dec 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 110.46 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -8.16% vs 33.13% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -10.51% vs 21.43% in Dec 2024

Quarterly - Interest

Interest 0.10 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -16.67% vs 0.00% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -33.33% vs -21.05% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 29.55%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024